Literature DB >> 7395838

Endoscopic surveillance for cancer in chronic ulcerative colitis.

J A Fuson, R G Farmer, A Hawk, B H Sullivan.   

Abstract

Severe epithelial dysplasia in multiple colonscopic biopsy specimens may held identify those patients with chronic ulcerating colitis (CUC) at highest risk for developing colonic cancer. This retrospective analysis of 75 patients with longstanding CUC studied by colonoscopy and biopsy disclosed 11 patients with cancer. Four of these cancers were detected by surveillance colonoscopy and seven were detected by diagnostic colonoscopy. There was a high correlation between the presence of dysplasia and cancer in the patients. Cancer was found in five of seven patients who underwent operation after colonoscopic biopsies showed severe dysplasia. No cancers were found at operation in 15 patients whose colonoscopic biopsy specimens were free of dysplasia. Dysplasia can be consistently identified. A reviewing pathologist agreed with the initial biopsy diagnosis in 59 of 64 cases (92%) and with the colectomy diagnosis in 18 of 21 (86%). Colonscopy with multiple biopsy specimens is a valuable surveillance technic. Patients without dysplasia on biopsy should have continued surveillance.

Entities:  

Mesh:

Year:  1980        PMID: 7395838

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  10 in total

1.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

Review 2.  Cancer surveillance in ulcerative colitis--a time for reappraisal.

Authors:  A T Axon
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

3.  Immunohistochemical evaluation of carcinoembryonic antigen, secretory component, and epithelial IgA in ulcerative colitis with dysplasia.

Authors:  T O Rognum; K Elgjo; O Fausa; P Brandtzaeg
Journal:  Gut       Date:  1982-02       Impact factor: 23.059

4.  Ulcerative colitis with overexpression of p53 preceding overt histological abnormalities of the epithelium.

Authors:  K Matsuda; H Watanabe; Y Ajioka; M Kobayashi; H Saito; M Sasaki; K Yasuda; A Kuwabara; K Nishikura; T Muto
Journal:  J Gastroenterol       Date:  1996-12       Impact factor: 7.527

Review 5.  Failure of colonoscopic surveillance in ulcerative colitis.

Authors:  D A Lynch; A J Lobo; G M Sobala; M F Dixon; A T Axon
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

6.  Cancer surveillance of patients with longstanding ulcerative colitis: a clinical, endoscopical, and histological study.

Authors:  O Broström; R Löfberg; A Ost; H Reichard
Journal:  Gut       Date:  1986-12       Impact factor: 23.059

7.  Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval.

Authors:  A Sugita; D B Sachar; C Bodian; M B Ribeiro; A H Aufses; A J Greenstein
Journal:  Gut       Date:  1991-02       Impact factor: 23.059

Review 8.  Techniques for targeting screening in ulcerative colitis.

Authors:  David Paul Hurlstone; Steve Brown
Journal:  Postgrad Med J       Date:  2007-07       Impact factor: 2.401

9.  Large bowel mucosal dysplasia and carcinoma in ulcerative colitis.

Authors:  D C Allen; J D Biggart; P C Pyper
Journal:  J Clin Pathol       Date:  1985-01       Impact factor: 3.411

10.  Colorectal Oncogenesis and Inflammation in a Rat Model Based on Chronic Inflammation due to Cycling DSS Treatments.

Authors:  Asa Håkansson; Camilla Bränning; Göran Molin; Diya Adawi; Marie-Louise Hagslätt; Margareta Nyman; Bengt Jeppsson; Siv Ahrné
Journal:  Gastroenterol Res Pract       Date:  2011-10-05       Impact factor: 2.260

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.